dc.contributor.author |
Isik, B |
|
dc.contributor.author |
Yilmaz, S |
|
dc.contributor.author |
Kirimlioglu, V |
|
dc.contributor.author |
Kirimlioglu, H |
|
dc.contributor.author |
Yilmaz, M |
|
dc.contributor.author |
Sogutlu, G |
|
dc.contributor.author |
Ara, C |
|
dc.contributor.author |
Katz, D |
|
dc.date.accessioned |
2022-03-18T12:38:05Z |
|
dc.date.available |
2022-03-18T12:38:05Z |
|
dc.date.issued |
2008 |
|
dc.identifier.uri |
http://hdl.handle.net/11616/56588 |
|
dc.description.abstract |
The transplantation of organs from donors who have undergone shunt surgery or craniotomy for a malignant central nervous system (CNS) tumor is controversial. We report a case of Kaposi's sarcoma (KS) developing as a result of immunosuppression in the recipient of a liver transplant from a donor who underwent craniotomy and ventriculoperitoneal shunt surgery for primary CNS lymphoma. Polymerase chain reaction assay did not isolate human herpes virus-8 in the Kaposi lesions. To our knowledge, this is the only case ever reported of KS developing after liver transplantation from a donor with lymphoma. Thus, with appropriate screening to exclude possible dissemination, patients with a history of high-grade primary CNS lymphoma treated by ventriculoperitoneal shunt and craniotomy may be accepted as donors. |
|
dc.source |
SURGERY TODAY |
|
dc.title |
Kaposi's sarcoma after liver transplantation from a donor with a history |
|
dc.title |
of ventriculoperitoneal shunt and craniotomy for primary central nervous |
|
dc.title |
system lymphoma: Report of a case |
|